Single B Cell Screening

Antibody discovery has traditionally relied on selecting clones based on target binding. However, for therapeutic applications, the desired antibodies must also drive a functional response, such as receptor activation, T cell stimulation, or signaling modulation. Identifying these antibodies early in discovery can significantly reduce downstream risk and accelerate lead optimization.

Over the past four decades, antibody discovery platforms have transformed biotherapeutics. Hybridoma technology, developed in 1975, pioneered the production of monoclonal antibodies, while more recent advances in single B cell screening have expanded access to rare, high-affinity clones.

Single-cell antibody sequencing reveals repertoire diversity. Biointron applies this method to uncover potent candidates for therapeutic antibody programs.

High-throughput single B cell screening is transforming discovery. Biointron demonstrates how advanced platforms accelerate identification of potent antibodies.

Single B cell screening accelerates discovery. Biointron demonstrates how this technology identifies potent antibodies faster, guiding therapeutic development.

Single B cell technology accelerates antibody discovery. Biointron demonstrates how this approach delivers potent candidates faster and with greater precision.

Plasma cells secrete vast amounts of antibodies. Biointron describes their differentiation from B cells and the importance of this process in immune defense.

B cell activation depends on complex signaling. Biointron outlines the pathways and checkpoints that regulate antibody generation and adaptive immunity.

Antigen recognition initiates immune defense. Biointron explains how B cell activation shapes antibody production and drives effective immune responses.

High-throughput antibody production changes the pace of biotech. Learn how automation and  Single B Cell Screening deliver thousands of antibodies with speed and quality.

Antibody screening turns vast sequence space into usable leads. Compare phage display, single‑B‑cell methods, and library strategies, with tips to boost hit quality.